- Home
- AKRO vs GLOB Comparison
AKRO vs GLOB Comparison
Compare AKRO & GLOB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- GLOB
- Stock Information
- Founded
- AKRO 2017
- GLOB 2003
- Country
- AKRO United States
- GLOB Luxembourg
- Employees
- AKRO N/A
- GLOB N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- GLOB EDP Services
- Sector
- AKRO Health Care
- GLOB Technology
- Exchange
- AKRO Nasdaq
- GLOB Nasdaq
- Market Cap
- AKRO 4.5B
- GLOB 4.7B
- IPO Year
- AKRO 2019
- GLOB 2014
- Fundamental
- Price
- AKRO $54.34
- GLOB $59.84
- Analyst Decision
- AKRO Buy
- GLOB Buy
- Analyst Count
- AKRO 10
- GLOB 15
- Target Price
- AKRO $73.56
- GLOB $118.60
- AVG Volume (30 Days)
- AKRO 1.7M
- GLOB 1.5M
- Earning Date
- AKRO 11-07-2025
- GLOB 11-13-2025
- Dividend Yield
- AKRO N/A
- GLOB N/A
- EPS Growth
- AKRO N/A
- GLOB N/A
- EPS
- AKRO N/A
- GLOB 2.19
- Revenue
- AKRO N/A
- GLOB $2,484,891,000.00
- Revenue This Year
- AKRO N/A
- GLOB $3.49
- Revenue Next Year
- AKRO N/A
- GLOB $2.36
- P/E Ratio
- AKRO N/A
- GLOB $27.84
- Revenue Growth
- AKRO N/A
- GLOB 5.56
- 52 Week Low
- AKRO $21.34
- GLOB $54.36
- 52 Week High
- AKRO $58.40
- GLOB $235.08
- Technical
- Relative Strength Index (RSI)
- AKRO 68.92
- GLOB 48.29
- Support Level
- AKRO $54.10
- GLOB $58.43
- Resistance Level
- AKRO $54.37
- GLOB $65.14
- Average True Range (ATR)
- AKRO 0.18
- GLOB 2.85
- MACD
- AKRO -0.22
- GLOB -0.07
- Stochastic Oscillator
- AKRO 89.00
- GLOB 27.46
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About GLOB Globant S.A.
Globant is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2003 in Argentina but is currently headquartered in Luxembourg and primarily serves clients in the US and Latin America. Globant's client base is relatively concentrated in the media and entertainment and financial services industries.